GlassScriptPhysician profile
Laura Hinman
NPI 1285080838
$6,637.74
in general payments reported to CMS, 2019-2025
38 companies · $1,766 in 2025
The $1,766 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $496 · 2020: $378 · 2021: $529 · 2022: $934 · 2023: $1,086 · 2024: $1,449 · 2025: $1,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,300.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $942.92 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $811.04 | 2019-2025 | |
| Abbvie INC. | $641.89 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $480.93 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Janssen Pharmaceuticals, INC | $415.97 | 2020-2024 | Xarelto |
| Glaxosmithkline, LLC. | $405.62 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Otsuka America Pharmaceutical, INC. | $355.75 | 2020-2025 | Rexulti |
| Lilly USA, LLC | $346.78 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $324.94 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $211.68 | 2020-2025 | Repatha, Otezla, Repatha |
| E.R. Squibb & Sons, L.L.C. | $207.72 | 2021-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $198.57 | 2019-2025 | |
| Dexcom, INC. | $182.86 | 2021-2024 | Dexcom G6 Transmitter |
| Biohaven Pharmaceutical Holding Company LTD. | $141.81 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.82 | 2019-2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Hinman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.